UI neuroendocrine tumor program earns high European distinction
University of Iowa Holden Comprehensive Cancer Center is the first U.S. cancer center to be designated a Neuroendocrine Tumor Center of Excellence by the European Neuroendocrine Tumor Society (ENETS). In making the award to the Iowa team in early March, ENETS listed its criteria for the distinction, including The Holden team’s advanced interdisciplinary approach for diagnosing neuroendocrine tumor (NET) patients The quality and breadth of the team’s medical treatments for NETS
You must be logged in to post a comment.